Home

Francisco D. Salva

CIK 1834051 · President and CEO · last filed 2026-06-18

Francisco D. Salva is a President and CEO who has filed 11 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for AZTR, was dated Jun 18, 2026. Across all open-market trades the lifetime net is +$100.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $531.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$531.6K

Companies

3

Total Filings

11

Lifetime Open-Market Net

$100.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AZTR President and CEO 4,086,291 $0.13 $531.6K $100.0K 6 2026-06-18
Vincerx Pharma, Inc. (VINC) Delisted Director — $0.01 — $0 4 2024-05-28
Vincerx Pharma, Inc. (VINCW) Delisted Director — $1.61 — $0 1 2020-12-28

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 AZTR Conv (C) +4,064,050 $0 EDGAR
2026-04-22 AZTR Grant (A) — $0 EDGAR
2026-03-20 AZTR Buy (P) — $0 EDGAR
2025-12-22 AZTR Grant (A) — $0 EDGAR
2024-05-28 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2024-02-15 AZTR Buy (P) +333,300 $100.0K EDGAR
2023-06-23 AZTR Grant (A) +5,000 $25.0K EDGAR
2023-05-30 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2022-05-31 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2021-05-14 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.